Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08

Rhea-AI Summary

Teladoc Health (NYSE:TDOC) has announced the issuance of inducement awards to five new employees. Four employees from the recently acquired Uplift Health Technologies received restricted stock units totaling 215,028 shares, vesting over two or three years based on continued service. Additionally, a new non-executive employee was granted 52,300 restricted stock units, with one-third vesting on the first anniversary and the remainder vesting quarterly over two years.

These awards were approved by Teladoc's Compensation Committee under the company's 2023 Employment Inducement Incentive Award Plan, complying with NYSE Rule 303A.08.

Positive

• Successful acquisition of Uplift Health Technologies, expanding company capabilities
• Retention strategy in place through restricted stock units for key acquired talent
• Structured vesting schedule promotes long-term employee commitment

Negative

• Stock-based compensation will lead to shareholder dilution
• Additional 267,328 shares to be issued, increasing outstanding shares

PURCHASE, N.Y., May 02, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to five new employees.

Effective April 30, 2025, in connection with the acquisition of Uplift Health Technologies, Inc., four employees of Uplift Health were granted awards of restricted stock units covering an aggregate of 215,028 shares of Teladoc Health’s common stock, par value $0.001 per share (“Common Stock”). The restricted stock units vest, based on continued service to Teladoc Health, over two or three years.

Also, effective May 1, 2025, in connection with commencing employment, an additional new non-executive employee of Teladoc Health was granted an award of restricted stock units covering 52,300 shares of Common Stock. The restricted stock units vest, based on continued service to Teladoc Health, as to one-third of the underlying shares on the first anniversary of the grant date, with the remainder vesting quarterly over two years thereafter.

The awards were approved by the Compensation Committee of the Board of Directors of Teladoc Health and were granted under the Teladoc Health, Inc. 2023 Employment Inducement Incentive Award Plan as employment inducement awards pursuant to New York Stock Exchange Rule 303A.08.

About Teladoc Health

Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Teladoc Health leverages more than two decades of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com.

Media:
Lou Serio
202-569-9715
PR@teladochealth.com

FAQ

How many shares of restricted stock units did Teladoc Health (TDOC) issue in May 2025?

Teladoc Health issued a total of 267,328 restricted stock units - 215,028 shares to four Uplift Health employees and 52,300 shares to a new non-executive employee.

What is the vesting schedule for TDOC's inducement awards issued in May 2025?

Uplift Health employees' RSUs vest over 2-3 years. The new non-executive employee's RSUs vest 1/3 after one year, with the remainder vesting quarterly over two years.

Why did Teladoc Health (TDOC) issue inducement awards in May 2025?

The awards were issued in connection with the acquisition of Uplift Health Technologies and to attract a new non-executive employee, as employment inducement awards under NYSE Rule 303A.08.

When were the Teladoc Health (TDOC) inducement awards approved and under what plan?

The awards were approved by Teladoc's Compensation Committee under the 2023 Employment Inducement Incentive Award Plan, complying with NYSE Rule 303A.08.